ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use
August 17, 2021Avidity Biosciences, Inc. today announced its collaboration with the Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trial Research Network (FSHD CTRN) to support a natural history study for people living with FSHD called the Motor Outcomes. -
Avidity Biosciences Announces Proposed Public Offering of Common Stock
August 03, 2021Avidity Biosciences, Inc. (Nasdaq: RNA) today announced that it intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.
Pharma Sources Insight January 2025
